[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Pr√©sentation",
    "section": "",
    "text": "Agr√©gation, chronologie et journalisation sur ma sant√©. &gt; Le Fran√ßais occasionel est seulement pour pratiquer la production de texte.\n\n\n\n\n\n\n\n\n\n\nPriority\nMain Mechanisms\nKey Compounds Involved\n\n\n\n\nLiver Support\nBile flow, detoxification, antioxidant protection\nUrsacol, Silymarin, NAC, Methionine, Choline, Omega-3, MSM\n\n\nAnti-inflammatory Control (Systemic + Colon)\nCytokine modulation, gut barrier repair\nAdalimumab, Mesalazine, Omega-3, Curcumin (Golden Milk), Probiotics\n\n\nSleep Optimization\nGABAergic, serotonin, and glycine pathways\nMagnesium (bisglycinate, taurinate), Theanine, Glycine, Inositol, possibly Quercetin (low-dose)\n\n\n\n\n\n\n\n\n\n\nMechanism: Hydrophilic bile acid ‚Üí replaces toxic bile salts ‚Üí reduces cholestasis & inflammation in PSC.\nDose: You‚Äôre at ~1.5 g/day, which is above the high-therapeutic range (13‚Äì15 mg/kg/day).\nOptimization: Maintain divided dosing (morning + bedtime) for even bile acid pool modulation.\n\n\n\n\n\nStrong hepatoprotective flavonolignan complex; up-regulates glutathione synthesis and down-regulates NF-Œ∫B.\n\n\n\n\n\nKey methyl donors and bile-mobilizing nutrients.\nTwice-daily use is good; consider moving the evening dose earlier (around 17‚Äì18 h) to avoid potential mild stimulatory effects that could delay sleep.\n\n\n\n\n\nIdeal for PSC/UC overlap: boosts hepatic glutathione, reduces bile viscosity, and supports mucosal protection.\nNighttime dose supports liver redox overnight.\n\n\n\n\n\nSynergistic with NAC in thiol replenishment and inflammation control.\nKeep spacing (1 g midday, 1 g dinner, 2 g bedtime) ‚Äî this pattern supports connective tissue repair and mild sedative synergy via sulfur metabolism.\n\n\n\n\n\n\n\n\n\nExcellent baseline for mucosal control. Continue as prescribed.\n\n\n\n\n\nMaintain with lipid vehicle (milk) + black pepper for absorption.\nIf tolerated, you could increase to twice daily for enhanced systemic anti-inflammatory effect.\n\n\n\n\n\nAnti-TNF and anti-fibrotic; this is an optimal anti-inflammatory range.\nContinue splitting across meals.\n\n\n\n\n\nExcellent combo: immune modulation + intestinal permeability control.\nContinue both; consider cycling with a Bifidobacterium-dominant strain every few months for microbiome diversity. &gt; ‚ö†Ô∏è Take at least 4h away from Bactrim\n\n\n\n\n\n\n\n\n\nEnhances slow-wave sleep and thermoregulation.\n\n\n\n\n\nActs on serotonin and acetylcholine signaling, improving sleep initiation and calmness.\nKeep at bedtime; synergistic with magnesium and theanine.\n\n\n\n\n\nExcellent anxiolytic without sedation.\nYou may experiment with dividing it: 100 mg mid-afternoon + 150 mg bedtime for smoother effect.\n\n\n\n\n\nExcellent selection of forms: bisglycinate (CNS-calming), malate (energy), taurinate (GABAergic).\nMaintain one dose morning, one pre-bed. Avoid excessive citrate later in the day (can cause bowel movement stimulation).\n\n\n\n\n\nBeneficial for digestion, but empty stomach use may irritate gastric mucosa; dilute it well or take after food.\n\n\n\n\n\n\n\n\n\nPotent anti-inflammatory, mast-cell stabilizer, and antifibrotic (especially relevant for PSC).\nIt enhances NAC + Silymarin synergy and may aid sleep through lowering histamine and oxidative stress.\n\n\n\n\n\n\n\n\n\n\n\nTiming\nDose\nPurpose\n\n\n\n\nLunch\n500 mg\nAnti-inflammatory synergy with Silymarin, NAC\n\n\nBedtime\n500 mg\nAntihistaminic / sleep enhancement via H1-blockade and GABA modulation\n\n\n\n\n‚ö†Ô∏è Avoid combining high quercetin with high-dose iron (Noripurum): it inhibits iron absorption. Space at least 3 h apart.\n\n\n\n\n\n\n\n\n\n\nüçé Apple Cider Vinegar: 1 to 3 spoons (after breakfast)\nüíä Bactrim:\nüíä Ursacol: 2 x 300mg\nüíä Mesalazine: 1 x 500mg\nüíâ Adalimumab: 1 x 40mg (weekly)\n‚ö° Magnesium complex: 2 x 117mg\nüèãÔ∏è Creatine: 10g\n\n\n\n\n\n\nü¶¥ Calcium: 1 x 500 mg\nüåû Vitamin D3: 2 x 2000 IU\nüï∏Ô∏è Racemetionine: 2 x 100mg\nüï∏Ô∏è Choline Clorate: 2 x 20mg\nüï∏Ô∏è Silymarin: 2 x 200 mg\nüõ°Ô∏è NAC: 1.5g\nüêü Omega-3: 2 x 0.8 g\nüß† Phosphatidylserine: 2 x 50 mg\nü¶µ MSM 1g\nüõ°Ô∏è Quercetin: 1 x 500 mg\n\n\n\n\n\n\n‚ú® Golden-milk (7 g) + black pepper\nüçä Vitamin C (1 g)\nüî© Noripurum (20 drops) ‚Üí (avoid 3 h around quercetin/NAC)\nüï∏Ô∏è Racemetionine: 2 x 100mg\nüï∏Ô∏è Choline Clorate: 2 x 20mg\n\n\n\n\n\n\nüêü Omega-3: 2 x 0.8 g\nüß† Phosphatidylserine: 2 x 50 mg\nü¶µ MSM 1g\nü¶† Smart L. rhamnosus: 2 x 1g\nü¶† NutrioneLife sachet: 1 x 5g\n\n\n\n\n\n\nüíä Ursacol: 3 x 300mg\nüõ°Ô∏è NAC: 1.5g\nüï∏Ô∏è Silymarin: 2 x 200 mg\nü¶µ MSM: 2g\nüí§ Glycine: 3g\nüí§ Myo-inositol: 3g\nüõ°Ô∏è Quercetin: 1 x 500 mg\n\n\n\n\n\n\n\n\n\n\n\n\n\nFocus\nRecommendation\n\n\n\n\nIron absorption\nMaintain Noripurum away from quercetin, NAC, and calcium.\n\n\nBowel motility\nIf stools become too loose, shift part of magnesium dose earlier or reduce citrate fraction.\n\n\nMethylation balance\nYou might later add Trimethylglycine (TMG 500 mg) alongside Methionine + Choline for full methyl-cycle support.\n\n\nInflammatory control\nCurcumin + Omega-3 + Adalimumab + Quercetin + Silymarin create an excellent anti-NF-Œ∫B network; avoid unnecessary NSAIDs.\n\n\nSleep\nMaintain fixed bedtime, dim light 1 h before, magnesium/glycine/theanine/inositol at least 30 min pre-sleep.\n\n\n\n\n\n\n\n\n‚úÖ Strong hepatoprotection: Ursacol + Silymarin + NAC + MSM\n‚úÖ Anti-inflammatory synergy: Adalimumab + Omega-3 + Curcumin + Quercetin\n‚úÖ Sleep foundation: Magnesium bisglycinate + Theanine + Glycine + Inositol\n‚ö†Ô∏è Manage supplement timing to avoid absorption conflicts (iron ‚ÜîÔ∏é quercetin/NAC).\n‚öôÔ∏è Optionally recheck hepatic enzymes (Œ≥-GT, ALP) after 6‚Äì8 weeks on this adjusted plan to quantify benefit.\n\n\n\n\n\nGoals impacted: Sleep optimization ‚Ä¢ Liver/PSC (GGT/ALP) ‚Ä¢ UC inflammation\n\n\n\nTMG (Trimethylglycine) ‚Äî 500 mg morning + 500 mg dinner ‚Üí supports BHMT remethylation and bile flow synergy with methionine/choline.\nMelatonin ‚Äî 1‚Äì3 mg at bedtime (start 1 mg) ‚Üí sleep onset/maintenance; adjunct signals in UC.\nPsyllium husk ‚Äî 10 g morning + 10 g dinner (‚â•250‚Äì300 mL water) ‚Üí UC maintenance; separate meds by ~2 h.\nProbiotic step-up (OPTIONAL):\n\nVSL#3 / De Simone formulation ‚Äî 450‚Äì900B CFU in the afternoon (‚â•3‚Äì4 h after Bactrim).\nE. coli Nissle 1917 (Mutaflor) ‚Äî per label (maintenance).\n\nVitamin K2 (MK-7) ‚Äî 100‚Äì200 ¬µg with dinner (consider water-miscible form if cholestasis).\nSAMe ‚Äî 400 mg morning + 400 mg afternoon ‚Üí cholestasis adjunct; monitor ALP/GGT, mood/sleep.\nTaurine ‚Äî 1 g morning + 1 g dinner ‚Üí bile acid conjugation support.\nBoswellia (AKBA-standardized) ‚Äî 300‚Äì500 mg lunch + dinner ‚Üí adjunct anti-inflammatory.\n\n\n\n\n\nPsyllium: separate from mesalazine, calcium, iron, quercetin, NAC by ~2 hours.\nProbiotics vs Bactrim: dose ‚â•3‚Äì4 h after antibiotic (placed in Afternoon).\nIron (Noripurum): keep away from quercetin/tea/coffee/calcium by ‚â•2 h (you already pair with vitamin C).\nMethylation stack: TMG + Methionine/Choline ¬± SAMe ‚Üí check homocysteine after 6‚Äì8 weeks (target ~6‚Äì9 ¬µmol/L).\nStimulation: SAMe can be alerting ‚Üí avoid late evening; shift earlier if sleep impacted.\n\n\n\n\n\nLiver: GGT, ALP, bilirubin.\nMethylation: Homocysteine.\nCholestasis fat-solubles: Vitamins A, D, E, K (replete as needed; K2 added).\nLipids: watch LDL-C with TMG/SAMe changes."
  },
  {
    "objectID": "index.html#overview-of-goals",
    "href": "index.html#overview-of-goals",
    "title": "Pr√©sentation",
    "section": "",
    "text": "Priority\nMain Mechanisms\nKey Compounds Involved\n\n\n\n\nLiver Support\nBile flow, detoxification, antioxidant protection\nUrsacol, Silymarin, NAC, Methionine, Choline, Omega-3, MSM\n\n\nAnti-inflammatory Control (Systemic + Colon)\nCytokine modulation, gut barrier repair\nAdalimumab, Mesalazine, Omega-3, Curcumin (Golden Milk), Probiotics\n\n\nSleep Optimization\nGABAergic, serotonin, and glycine pathways\nMagnesium (bisglycinate, taurinate), Theanine, Glycine, Inositol, possibly Quercetin (low-dose)"
  },
  {
    "objectID": "index.html#liver-biliary-support",
    "href": "index.html#liver-biliary-support",
    "title": "Pr√©sentation",
    "section": "",
    "text": "Mechanism: Hydrophilic bile acid ‚Üí replaces toxic bile salts ‚Üí reduces cholestasis & inflammation in PSC.\nDose: You‚Äôre at ~1.5 g/day, which is above the high-therapeutic range (13‚Äì15 mg/kg/day).\nOptimization: Maintain divided dosing (morning + bedtime) for even bile acid pool modulation.\n\n\n\n\n\nStrong hepatoprotective flavonolignan complex; up-regulates glutathione synthesis and down-regulates NF-Œ∫B.\n\n\n\n\n\nKey methyl donors and bile-mobilizing nutrients.\nTwice-daily use is good; consider moving the evening dose earlier (around 17‚Äì18 h) to avoid potential mild stimulatory effects that could delay sleep.\n\n\n\n\n\nIdeal for PSC/UC overlap: boosts hepatic glutathione, reduces bile viscosity, and supports mucosal protection.\nNighttime dose supports liver redox overnight.\n\n\n\n\n\nSynergistic with NAC in thiol replenishment and inflammation control.\nKeep spacing (1 g midday, 1 g dinner, 2 g bedtime) ‚Äî this pattern supports connective tissue repair and mild sedative synergy via sulfur metabolism."
  },
  {
    "objectID": "index.html#anti-inflammatory-gut-support",
    "href": "index.html#anti-inflammatory-gut-support",
    "title": "Pr√©sentation",
    "section": "",
    "text": "Excellent baseline for mucosal control. Continue as prescribed.\n\n\n\n\n\nMaintain with lipid vehicle (milk) + black pepper for absorption.\nIf tolerated, you could increase to twice daily for enhanced systemic anti-inflammatory effect.\n\n\n\n\n\nAnti-TNF and anti-fibrotic; this is an optimal anti-inflammatory range.\nContinue splitting across meals.\n\n\n\n\n\nExcellent combo: immune modulation + intestinal permeability control.\nContinue both; consider cycling with a Bifidobacterium-dominant strain every few months for microbiome diversity. &gt; ‚ö†Ô∏è Take at least 4h away from Bactrim"
  },
  {
    "objectID": "index.html#sleep-optimization",
    "href": "index.html#sleep-optimization",
    "title": "Pr√©sentation",
    "section": "",
    "text": "Enhances slow-wave sleep and thermoregulation.\n\n\n\n\n\nActs on serotonin and acetylcholine signaling, improving sleep initiation and calmness.\nKeep at bedtime; synergistic with magnesium and theanine.\n\n\n\n\n\nExcellent anxiolytic without sedation.\nYou may experiment with dividing it: 100 mg mid-afternoon + 150 mg bedtime for smoother effect.\n\n\n\n\n\nExcellent selection of forms: bisglycinate (CNS-calming), malate (energy), taurinate (GABAergic).\nMaintain one dose morning, one pre-bed. Avoid excessive citrate later in the day (can cause bowel movement stimulation).\n\n\n\n\n\nBeneficial for digestion, but empty stomach use may irritate gastric mucosa; dilute it well or take after food."
  },
  {
    "objectID": "index.html#quercetin-integration",
    "href": "index.html#quercetin-integration",
    "title": "Pr√©sentation",
    "section": "",
    "text": "Potent anti-inflammatory, mast-cell stabilizer, and antifibrotic (especially relevant for PSC).\nIt enhances NAC + Silymarin synergy and may aid sleep through lowering histamine and oxidative stress.\n\n\n\n\n\n\n\n\n\n\n\nTiming\nDose\nPurpose\n\n\n\n\nLunch\n500 mg\nAnti-inflammatory synergy with Silymarin, NAC\n\n\nBedtime\n500 mg\nAntihistaminic / sleep enhancement via H1-blockade and GABA modulation\n\n\n\n\n‚ö†Ô∏è Avoid combining high quercetin with high-dose iron (Noripurum): it inhibits iron absorption. Space at least 3 h apart."
  },
  {
    "objectID": "index.html#adjusted-schedule-summary",
    "href": "index.html#adjusted-schedule-summary",
    "title": "Pr√©sentation",
    "section": "",
    "text": "üçé Apple Cider Vinegar: 1 to 3 spoons (after breakfast)\nüíä Bactrim:\nüíä Ursacol: 2 x 300mg\nüíä Mesalazine: 1 x 500mg\nüíâ Adalimumab: 1 x 40mg (weekly)\n‚ö° Magnesium complex: 2 x 117mg\nüèãÔ∏è Creatine: 10g\n\n\n\n\n\n\nü¶¥ Calcium: 1 x 500 mg\nüåû Vitamin D3: 2 x 2000 IU\nüï∏Ô∏è Racemetionine: 2 x 100mg\nüï∏Ô∏è Choline Clorate: 2 x 20mg\nüï∏Ô∏è Silymarin: 2 x 200 mg\nüõ°Ô∏è NAC: 1.5g\nüêü Omega-3: 2 x 0.8 g\nüß† Phosphatidylserine: 2 x 50 mg\nü¶µ MSM 1g\nüõ°Ô∏è Quercetin: 1 x 500 mg\n\n\n\n\n\n\n‚ú® Golden-milk (7 g) + black pepper\nüçä Vitamin C (1 g)\nüî© Noripurum (20 drops) ‚Üí (avoid 3 h around quercetin/NAC)\nüï∏Ô∏è Racemetionine: 2 x 100mg\nüï∏Ô∏è Choline Clorate: 2 x 20mg\n\n\n\n\n\n\nüêü Omega-3: 2 x 0.8 g\nüß† Phosphatidylserine: 2 x 50 mg\nü¶µ MSM 1g\nü¶† Smart L. rhamnosus: 2 x 1g\nü¶† NutrioneLife sachet: 1 x 5g\n\n\n\n\n\n\nüíä Ursacol: 3 x 300mg\nüõ°Ô∏è NAC: 1.5g\nüï∏Ô∏è Silymarin: 2 x 200 mg\nü¶µ MSM: 2g\nüí§ Glycine: 3g\nüí§ Myo-inositol: 3g\nüõ°Ô∏è Quercetin: 1 x 500 mg"
  },
  {
    "objectID": "index.html#strategic-observations",
    "href": "index.html#strategic-observations",
    "title": "Pr√©sentation",
    "section": "",
    "text": "Focus\nRecommendation\n\n\n\n\nIron absorption\nMaintain Noripurum away from quercetin, NAC, and calcium.\n\n\nBowel motility\nIf stools become too loose, shift part of magnesium dose earlier or reduce citrate fraction.\n\n\nMethylation balance\nYou might later add Trimethylglycine (TMG 500 mg) alongside Methionine + Choline for full methyl-cycle support.\n\n\nInflammatory control\nCurcumin + Omega-3 + Adalimumab + Quercetin + Silymarin create an excellent anti-NF-Œ∫B network; avoid unnecessary NSAIDs.\n\n\nSleep\nMaintain fixed bedtime, dim light 1 h before, magnesium/glycine/theanine/inositol at least 30 min pre-sleep."
  },
  {
    "objectID": "index.html#key-takeaways",
    "href": "index.html#key-takeaways",
    "title": "Pr√©sentation",
    "section": "",
    "text": "‚úÖ Strong hepatoprotection: Ursacol + Silymarin + NAC + MSM\n‚úÖ Anti-inflammatory synergy: Adalimumab + Omega-3 + Curcumin + Quercetin\n‚úÖ Sleep foundation: Magnesium bisglycinate + Theanine + Glycine + Inositol\n‚ö†Ô∏è Manage supplement timing to avoid absorption conflicts (iron ‚ÜîÔ∏é quercetin/NAC).\n‚öôÔ∏è Optionally recheck hepatic enzymes (Œ≥-GT, ALP) after 6‚Äì8 weeks on this adjusted plan to quantify benefit."
  },
  {
    "objectID": "index.html#additions-2025-10-08",
    "href": "index.html#additions-2025-10-08",
    "title": "Pr√©sentation",
    "section": "",
    "text": "Goals impacted: Sleep optimization ‚Ä¢ Liver/PSC (GGT/ALP) ‚Ä¢ UC inflammation\n\n\n\nTMG (Trimethylglycine) ‚Äî 500 mg morning + 500 mg dinner ‚Üí supports BHMT remethylation and bile flow synergy with methionine/choline.\nMelatonin ‚Äî 1‚Äì3 mg at bedtime (start 1 mg) ‚Üí sleep onset/maintenance; adjunct signals in UC.\nPsyllium husk ‚Äî 10 g morning + 10 g dinner (‚â•250‚Äì300 mL water) ‚Üí UC maintenance; separate meds by ~2 h.\nProbiotic step-up (OPTIONAL):\n\nVSL#3 / De Simone formulation ‚Äî 450‚Äì900B CFU in the afternoon (‚â•3‚Äì4 h after Bactrim).\nE. coli Nissle 1917 (Mutaflor) ‚Äî per label (maintenance).\n\nVitamin K2 (MK-7) ‚Äî 100‚Äì200 ¬µg with dinner (consider water-miscible form if cholestasis).\nSAMe ‚Äî 400 mg morning + 400 mg afternoon ‚Üí cholestasis adjunct; monitor ALP/GGT, mood/sleep.\nTaurine ‚Äî 1 g morning + 1 g dinner ‚Üí bile acid conjugation support.\nBoswellia (AKBA-standardized) ‚Äî 300‚Äì500 mg lunch + dinner ‚Üí adjunct anti-inflammatory.\n\n\n\n\n\nPsyllium: separate from mesalazine, calcium, iron, quercetin, NAC by ~2 hours.\nProbiotics vs Bactrim: dose ‚â•3‚Äì4 h after antibiotic (placed in Afternoon).\nIron (Noripurum): keep away from quercetin/tea/coffee/calcium by ‚â•2 h (you already pair with vitamin C).\nMethylation stack: TMG + Methionine/Choline ¬± SAMe ‚Üí check homocysteine after 6‚Äì8 weeks (target ~6‚Äì9 ¬µmol/L).\nStimulation: SAMe can be alerting ‚Üí avoid late evening; shift earlier if sleep impacted.\n\n\n\n\n\nLiver: GGT, ALP, bilirubin.\nMethylation: Homocysteine.\nCholestasis fat-solubles: Vitamins A, D, E, K (replete as needed; K2 added).\nLipids: watch LDL-C with TMG/SAMe changes."
  },
  {
    "objectID": "QUARTO_SETUP.html",
    "href": "QUARTO_SETUP.html",
    "title": "Quarto Multi-Page Site Setup",
    "section": "",
    "text": "This document describes the Quarto configuration for the maladie health tracking website.\n\n\nThe site is now a multi-page Quarto website with the following pages:\n\nHome (/ or /index.html) - The main page from README.md containing supplement schedule and health goals\nBlood Markers (/blood.html) - Interactive blood test results visualization\nMedications (/meds.html) - Medication and supplementation timeline visualization\n\n\n\n\n\n\n\n_quarto.yml - Main Quarto configuration file\n\n\n\n\n\nindex.qmd - Copy of README.md, serves as the home page\nblood.qmd - Page that embeds the blood markers visualization\nmeds.qmd - Page that embeds the medications timeline\n\n\n\n\n\nblood_standalone.html - Original index.html with blood markers analysis\nmeds_standalone.html - Copy of meds_and_supplements/meds.html\n\n\n\n\n\nblood_markers_pivot.csv - Blood test data\nreports.json - Medical reports metadata\nmeds_and_supplements/med_schedule.json - Medication schedule data\n\n\n\n\n\nTo rebuild the site after making changes:\nquarto render\nThis will regenerate all HTML files in the docs/ directory.\n\n\n\nThe site is configured to deploy to GitHub Pages from the docs/ directory.\n\n\n\nGo to repository Settings ‚Üí Pages\nSet Source to ‚ÄúDeploy from a branch‚Äù\nSet Branch to ‚Äúmain‚Äù (or your default branch)\nSet Folder to ‚Äú/docs‚Äù\nSave\n\nThe site will be available at: https://maladie.ronaldo.tech\n\n\n\n\n\n\n\nCreate a new .qmd file in the root directory\nAdd the page to the navbar in _quarto.yml\nRun quarto render to regenerate the site\n\n\n\n\n\nUpdate CSV/JSON files in the root directory\nThe data files are automatically copied to docs/ during render\nRun quarto render to update\n\n\n\n\n\nEdit blood_standalone.html or meds_standalone.html\nRun quarto render to copy changes to docs/"
  },
  {
    "objectID": "QUARTO_SETUP.html#structure",
    "href": "QUARTO_SETUP.html#structure",
    "title": "Quarto Multi-Page Site Setup",
    "section": "",
    "text": "The site is now a multi-page Quarto website with the following pages:\n\nHome (/ or /index.html) - The main page from README.md containing supplement schedule and health goals\nBlood Markers (/blood.html) - Interactive blood test results visualization\nMedications (/meds.html) - Medication and supplementation timeline visualization"
  },
  {
    "objectID": "QUARTO_SETUP.html#files-created",
    "href": "QUARTO_SETUP.html#files-created",
    "title": "Quarto Multi-Page Site Setup",
    "section": "",
    "text": "_quarto.yml - Main Quarto configuration file\n\n\n\n\n\nindex.qmd - Copy of README.md, serves as the home page\nblood.qmd - Page that embeds the blood markers visualization\nmeds.qmd - Page that embeds the medications timeline\n\n\n\n\n\nblood_standalone.html - Original index.html with blood markers analysis\nmeds_standalone.html - Copy of meds_and_supplements/meds.html\n\n\n\n\n\nblood_markers_pivot.csv - Blood test data\nreports.json - Medical reports metadata\nmeds_and_supplements/med_schedule.json - Medication schedule data"
  },
  {
    "objectID": "QUARTO_SETUP.html#building-the-site",
    "href": "QUARTO_SETUP.html#building-the-site",
    "title": "Quarto Multi-Page Site Setup",
    "section": "",
    "text": "To rebuild the site after making changes:\nquarto render\nThis will regenerate all HTML files in the docs/ directory."
  },
  {
    "objectID": "QUARTO_SETUP.html#deployment",
    "href": "QUARTO_SETUP.html#deployment",
    "title": "Quarto Multi-Page Site Setup",
    "section": "",
    "text": "The site is configured to deploy to GitHub Pages from the docs/ directory.\n\n\n\nGo to repository Settings ‚Üí Pages\nSet Source to ‚ÄúDeploy from a branch‚Äù\nSet Branch to ‚Äúmain‚Äù (or your default branch)\nSet Folder to ‚Äú/docs‚Äù\nSave\n\nThe site will be available at: https://maladie.ronaldo.tech"
  },
  {
    "objectID": "QUARTO_SETUP.html#maintenance",
    "href": "QUARTO_SETUP.html#maintenance",
    "title": "Quarto Multi-Page Site Setup",
    "section": "",
    "text": "Create a new .qmd file in the root directory\nAdd the page to the navbar in _quarto.yml\nRun quarto render to regenerate the site\n\n\n\n\n\nUpdate CSV/JSON files in the root directory\nThe data files are automatically copied to docs/ during render\nRun quarto render to update\n\n\n\n\n\nEdit blood_standalone.html or meds_standalone.html\nRun quarto render to copy changes to docs/"
  },
  {
    "objectID": "WARP.html",
    "href": "WARP.html",
    "title": "WARP.md",
    "section": "",
    "text": "This file provides guidance to WARP (warp.dev) when working with code in this repository.\n\n\nmaladie is a health data visualization dashboard for analyzing time series blood marker data. It‚Äôs a single-page web application that creates interactive charts from CSV health data, allowing users to track biomarker evolution over time and identify out-of-range values.\n\n\n\n\n\n\nmain: Basic project setup (README, LICENSE)\nchart: Contains the complete application code and data\n\n\n\n\n\nindex.html: Complete interactive dashboard with embedded CSS/JavaScript\nblood_markers_pivot.csv: Health data in pivot format (columns are dates, rows are analytes)\n\n\n\n\n\n\n\n\nInput Format: CSV with analytes as rows, datetime columns, and reference ranges\nData Categories: Organized into functional groups (Inflammatory, Hematology, Kidney, Liver, etc.)\nValue Handling: Supports numeric values, special markers (‚Äú‚Äî-‚Äù, ‚ÄúInferior a 0.5‚Äù, ‚ÄúRaras‚Äù)\n\n\n\n\n\nTechnology: Pure HTML/CSS/JavaScript with Plotly.js for charting\nLoading: Automatic CSV loading with fallback to manual file picker\nVisualization: Interactive time series with reference ranges, historical min/max, median trends\nAnalysis: Real-time detection of out-of-range values with percentage deviations\n\n\n\n\n\nInteractive Charts: Zoom, pan, range slider for temporal navigation\nReference Ranges: Visual indication with green shaded areas\nTrend Analysis: Historical minimum/maximum lines, median trends\nFocus Box: Highlights latest out-of-range measurements with directional arrows\nData Export: Both pivot table and tidy format CSV downloads\nResponsive Design: Mobile-friendly interface\n\n\n\n\n\n\n\n# Serve locally (required due to CORS restrictions with CSV loading)\nuv run python -m http.server 8000\n# Then open http://localhost:8000/index.html\n\n\n\n# Switch to chart branch where code lives\ngit checkout chart\n\n# Check data structure\nhead blood_markers_pivot.csv\n\n# View recent changes to data\ngit --no-pager log --oneline -10\n\n\n\nThe project expects CSV data in a specific pivot format: - First column: Analyte names - Middle columns: DateTime values (DD/MM/YY HH:MM format)\n- Last column: Reference ranges with units - Values can be numeric, ‚Äú‚Äî-‚Äù (missing), or special text values\n\n\n\n# Start local server for testing\nuv run python -m http.server 8000\n\n# View application at:\n# http://localhost:8000/index.html\n\n\n\n\nThe application organizes analytes into functional groups: - Inflammatory: Prote√≠na C reativa, Calprotectina\n- Hematology: Complete blood count parameters - Kidney: Creatinina, Ureia - Liver: Liver function tests (TGO, TGP, Bilirubin, etc.) - Electrolytes/Minerals: Sodium, Potassium, Calcium, etc. - Lipids: Cholesterol panel - Hormones: Thyroid, reproductive hormones - Vitamins: B12, Folate, Vitamin D\n\n\n\n\nRequires modern browser with ES6+ support\nUses Plotly.js CDN for charting\nImplements manual file picker fallback for local file:// access\n\n\n\n\n\nNo server-side storage or processing\nAll analysis happens client-side\nPatient information should be anonymized in CSV data"
  },
  {
    "objectID": "WARP.html#project-overview",
    "href": "WARP.html#project-overview",
    "title": "WARP.md",
    "section": "",
    "text": "maladie is a health data visualization dashboard for analyzing time series blood marker data. It‚Äôs a single-page web application that creates interactive charts from CSV health data, allowing users to track biomarker evolution over time and identify out-of-range values."
  },
  {
    "objectID": "WARP.html#repository-structure",
    "href": "WARP.html#repository-structure",
    "title": "WARP.md",
    "section": "",
    "text": "main: Basic project setup (README, LICENSE)\nchart: Contains the complete application code and data\n\n\n\n\n\nindex.html: Complete interactive dashboard with embedded CSS/JavaScript\nblood_markers_pivot.csv: Health data in pivot format (columns are dates, rows are analytes)"
  },
  {
    "objectID": "WARP.html#key-architecture",
    "href": "WARP.html#key-architecture",
    "title": "WARP.md",
    "section": "",
    "text": "Input Format: CSV with analytes as rows, datetime columns, and reference ranges\nData Categories: Organized into functional groups (Inflammatory, Hematology, Kidney, Liver, etc.)\nValue Handling: Supports numeric values, special markers (‚Äú‚Äî-‚Äù, ‚ÄúInferior a 0.5‚Äù, ‚ÄúRaras‚Äù)\n\n\n\n\n\nTechnology: Pure HTML/CSS/JavaScript with Plotly.js for charting\nLoading: Automatic CSV loading with fallback to manual file picker\nVisualization: Interactive time series with reference ranges, historical min/max, median trends\nAnalysis: Real-time detection of out-of-range values with percentage deviations\n\n\n\n\n\nInteractive Charts: Zoom, pan, range slider for temporal navigation\nReference Ranges: Visual indication with green shaded areas\nTrend Analysis: Historical minimum/maximum lines, median trends\nFocus Box: Highlights latest out-of-range measurements with directional arrows\nData Export: Both pivot table and tidy format CSV downloads\nResponsive Design: Mobile-friendly interface"
  },
  {
    "objectID": "WARP.html#common-development-tasks",
    "href": "WARP.html#common-development-tasks",
    "title": "WARP.md",
    "section": "",
    "text": "# Serve locally (required due to CORS restrictions with CSV loading)\nuv run python -m http.server 8000\n# Then open http://localhost:8000/index.html\n\n\n\n# Switch to chart branch where code lives\ngit checkout chart\n\n# Check data structure\nhead blood_markers_pivot.csv\n\n# View recent changes to data\ngit --no-pager log --oneline -10\n\n\n\nThe project expects CSV data in a specific pivot format: - First column: Analyte names - Middle columns: DateTime values (DD/MM/YY HH:MM format)\n- Last column: Reference ranges with units - Values can be numeric, ‚Äú‚Äî-‚Äù (missing), or special text values\n\n\n\n# Start local server for testing\nuv run python -m http.server 8000\n\n# View application at:\n# http://localhost:8000/index.html"
  },
  {
    "objectID": "WARP.html#data-categories-and-groupings",
    "href": "WARP.html#data-categories-and-groupings",
    "title": "WARP.md",
    "section": "",
    "text": "The application organizes analytes into functional groups: - Inflammatory: Prote√≠na C reativa, Calprotectina\n- Hematology: Complete blood count parameters - Kidney: Creatinina, Ureia - Liver: Liver function tests (TGO, TGP, Bilirubin, etc.) - Electrolytes/Minerals: Sodium, Potassium, Calcium, etc. - Lipids: Cholesterol panel - Hormones: Thyroid, reproductive hormones - Vitamins: B12, Folate, Vitamin D"
  },
  {
    "objectID": "WARP.html#browser-compatibility",
    "href": "WARP.html#browser-compatibility",
    "title": "WARP.md",
    "section": "",
    "text": "Requires modern browser with ES6+ support\nUses Plotly.js CDN for charting\nImplements manual file picker fallback for local file:// access"
  },
  {
    "objectID": "WARP.html#data-privacy",
    "href": "WARP.html#data-privacy",
    "title": "WARP.md",
    "section": "",
    "text": "No server-side storage or processing\nAll analysis happens client-side\nPatient information should be anonymized in CSV data"
  },
  {
    "objectID": "Health_Report.html",
    "href": "Health_Report.html",
    "title": "Maladie - Health Tracking",
    "section": "",
    "text": "1. Acute Hepatic Crisis (September 12, 2025) Your most recent blood work shows a dramatic deterioration in liver function markers, with what appears to be a severe hepatobiliary crisis. This coincides precisely with your reported symptoms of fatigue, inflammation, excessive urination, and diarrhea.\n2. Cholestatic Pattern The elevation pattern suggests cholestatic injury (bile duct inflammation/obstruction) rather than pure hepatocellular damage, which is consistent with PSC exacerbation. The disproportionate rise in alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) compared to transaminases is classic for biliary tract pathology.\n3. Post-Infectious Complications The timeline is critical here: - August 5-14: Cholangitis hospitalization (bacterial infection of bile ducts) - August 31: C. difficile infection with UC flare - September 12: Acute decompensation\nThis sequence suggests you may be experiencing: - Recurrent cholangitis or incomplete resolution of the initial infection - PSC stricture progression triggered by recent infections - Post-infectious inflammatory response affecting both IBD and PSC\n\n\n\n\nRecurrent Ascending Cholangitis: The sudden enzyme elevation with systemic symptoms strongly suggests another episode of cholangitis, possibly due to bacterial seeding during your recent infections.\nDominant Stricture Development: PSC can develop dominant strictures that cause acute obstruction, leading to the dramatic enzyme elevations you‚Äôre experiencing.\nDrug-Induced Hepatotoxicity: If you received antibiotics for C. diff (likely vancomycin or fidaxomicin), there could be a component of medication-related liver injury, though this seems less likely given the cholestatic pattern.\nOverlap Syndrome Flare: The combination of UC flare and PSC exacerbation can create a severe inflammatory cascade affecting multiple organ systems.\n\n\n\n\nImmediate Concerns: - The multi-fold increase in liver enzymes with systemic symptoms suggests active biliary sepsis or severe cholestasis requiring urgent intervention - The fluid shifts (edema followed by diuresis) suggest possible hepatic decompensation\nShort-term Prognosis: With appropriate treatment, acute cholangitis typically responds well to antibiotics and biliary drainage if needed. However, given your recent infection history, you may need: - Extended antibiotic therapy - MRCP or ERCP to evaluate for dominant strictures - Possible biliary intervention (stenting/dilation)\nLong-term Considerations: - Recurrent cholangitis episodes accelerate PSC progression - Your young age at diagnosis (20) and now 20 years of disease duration puts you at higher risk for cirrhosis and need for transplant evaluation - The recent pattern of infections suggests your disease may be entering a more aggressive phase\nURGENT: You should seek immediate medical evaluation, preferably at a center with hepatology expertise. The combination of markedly elevated liver enzymes, systemic symptoms, and your PSC history warrants urgent assessment for cholangitis and possible biliary intervention."
  },
  {
    "objectID": "Health_Report.html#section",
    "href": "Health_Report.html#section",
    "title": "Maladie - Health Tracking",
    "section": "",
    "text": "1. Acute Hepatic Crisis (September 12, 2025) Your most recent blood work shows a dramatic deterioration in liver function markers, with what appears to be a severe hepatobiliary crisis. This coincides precisely with your reported symptoms of fatigue, inflammation, excessive urination, and diarrhea.\n2. Cholestatic Pattern The elevation pattern suggests cholestatic injury (bile duct inflammation/obstruction) rather than pure hepatocellular damage, which is consistent with PSC exacerbation. The disproportionate rise in alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) compared to transaminases is classic for biliary tract pathology.\n3. Post-Infectious Complications The timeline is critical here: - August 5-14: Cholangitis hospitalization (bacterial infection of bile ducts) - August 31: C. difficile infection with UC flare - September 12: Acute decompensation\nThis sequence suggests you may be experiencing: - Recurrent cholangitis or incomplete resolution of the initial infection - PSC stricture progression triggered by recent infections - Post-infectious inflammatory response affecting both IBD and PSC\n\n\n\n\nRecurrent Ascending Cholangitis: The sudden enzyme elevation with systemic symptoms strongly suggests another episode of cholangitis, possibly due to bacterial seeding during your recent infections.\nDominant Stricture Development: PSC can develop dominant strictures that cause acute obstruction, leading to the dramatic enzyme elevations you‚Äôre experiencing.\nDrug-Induced Hepatotoxicity: If you received antibiotics for C. diff (likely vancomycin or fidaxomicin), there could be a component of medication-related liver injury, though this seems less likely given the cholestatic pattern.\nOverlap Syndrome Flare: The combination of UC flare and PSC exacerbation can create a severe inflammatory cascade affecting multiple organ systems.\n\n\n\n\nImmediate Concerns: - The multi-fold increase in liver enzymes with systemic symptoms suggests active biliary sepsis or severe cholestasis requiring urgent intervention - The fluid shifts (edema followed by diuresis) suggest possible hepatic decompensation\nShort-term Prognosis: With appropriate treatment, acute cholangitis typically responds well to antibiotics and biliary drainage if needed. However, given your recent infection history, you may need: - Extended antibiotic therapy - MRCP or ERCP to evaluate for dominant strictures - Possible biliary intervention (stenting/dilation)\nLong-term Considerations: - Recurrent cholangitis episodes accelerate PSC progression - Your young age at diagnosis (20) and now 20 years of disease duration puts you at higher risk for cirrhosis and need for transplant evaluation - The recent pattern of infections suggests your disease may be entering a more aggressive phase\nURGENT: You should seek immediate medical evaluation, preferably at a center with hepatology expertise. The combination of markedly elevated liver enzymes, systemic symptoms, and your PSC history warrants urgent assessment for cholangitis and possible biliary intervention."
  },
  {
    "objectID": "Health_Report.html#section-1",
    "href": "Health_Report.html#section-1",
    "title": "Maladie - Health Tracking",
    "section": "16/09/25",
    "text": "16/09/25\n\nüîé Tend√™ncias atuais dos seus exames\n\nInflama√ß√£o (PCR / Prote√≠na C Reativa):\n\nSubiu com a infec√ß√£o/flare, mas vem caindo aos poucos de picos (~8‚Äì9 mg/dL) para cerca de 6,3 mg/dL em 16/09.\nIndica que a inflama√ß√£o ainda existe, mas est√° diminuindo.\n\nLeuc√≥citos:\n\nEstavam elevados (&gt;15 mil) durante a infec√ß√£o.\nAgora ca√≠ram para ~9,7 mil em 16/09, perto da faixa normal.\nSugere melhora da atividade infecciosa/inflamat√≥ria.\n\nPlaquetas:\n\nSubiram de ~410 mil ‚Üí quase 490 mil.\nIsso √© comum em inflama√ß√£o persistente ou estresse hep√°tico (trombocitose reativa).\nN√£o preocupa isoladamente, mas mostra que o organismo ainda est√° em estado pr√≥-inflamat√≥rio.\n\nEnzimas hep√°ticas:\n\nAST (TGO), ALT (TGP), GGT e Fosfatase Alcalina tiveram eleva√ß√£o acentuada no epis√≥dio de colestase.\nAgora parecem estabilizadas ou em leve queda, em linha com a resson√¢ncia (sem colangite aguda).\nO Tozacin pode estar ajudando a prevenir infec√ß√£o secund√°ria, enquanto a pr√≥pria PSC mant√©m as enzimas altas.\n\nBilirrubina:\n\nEst√° elevada, mas sem piora recente.\nBilirrubina est√°vel + PCR em queda √© sinal de que n√£o h√° piora obstrutiva/infecciosa no momento.\n\n\n\n\nüìà Interpreta√ß√£o cl√≠nica\n\nA infec√ß√£o por C. difficile (in√≠cio de setembro) desencadeou inflama√ß√£o sist√™mica e provavelmente precipitou o flare da RCU.\nA PSC complicou o quadro: as enzimas subiram, mas a resson√¢ncia afastou nova obstru√ß√£o.\nOs m√©dicos entraram com antibi√≥tico de amplo espectro (Tozacin) para proteger contra colangite bacteriana ‚Äî conduta razo√°vel considerando seu hist√≥rico (colangite aguda no in√≠cio de agosto).\nAgora, os exames sugerem:\n\nInfec√ß√£o sob controle (queda de leuc√≥citos e PCR).\nColite ulcerativa ainda ativa, mas melhorando.\nPSC est√°vel, sem sinais de piora aguda.\n\n\n\n\n‚è≥ Linha do tempo de recupera√ß√£o (t√≠pico, baseado nos seus dados)\n\nNesta semana: PCR e leuc√≥citos devem se aproximar da normalidade se a infec√ß√£o estiver realmente controlada.\n1‚Äì2 semanas: Enzimas hep√°ticas podem continuar altas, mas devem cair gradualmente se n√£o houver nova colangite.\nColite ulcerativa: a melhora pode demorar mais (algumas semanas), especialmente se houver ajuste de corticoide/biol√≥gicos.\nPSC: risco cr√¥nico ‚Äî objetivo √© estabilizar, n√£o normalizar completamente.\n\n\n\n‚ö†Ô∏è O que ainda pode acontecer\n\nSe enzimas hep√°ticas subirem novamente + febre ‚Üí suspeita de nova colangite.\nSe PCR n√£o cair ou plaquetas continuarem subindo ‚Üí pode indicar inflama√ß√£o cont√≠nua ou complica√ß√£o secund√°ria.\nSe bilirrubina aumentar muito ‚Üí pode haver nova obstru√ß√£o ou evento biliar.\n\n‚úÖ Resumo: Voc√™ est√° na fase de melhora da tempestade inflamat√≥ria/infecciosa: a C. diff e o flare da colite desencadearam o quadro, mas os antibi√≥ticos e o suporte hospitalar estabilizaram. A expectativa √© de melhora lenta e progressiva nas pr√≥ximas 1‚Äì2 semanas, desde que n√£o ocorra nova colangite ou reativa√ß√£o da RCU."
  }
]